923 related articles for article (PubMed ID: 31597273)
1. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
3. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
El-Gohary A; Hegazy A; Abbas M; Kamel N; Nasef SI
J Clin Lab Anal; 2016 Nov; 30(6):1135-1138. PubMed ID: 27184880
[TBL] [Abstract][Full Text] [Related]
4. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.
Zhang CX; Cai L; Shao K; Wu J; Zhou W; Cao LF; Chen TX
Pediatr Nephrol; 2018 May; 33(5):837-845. PubMed ID: 29264699
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis.
Abediazar S; Jafari-Nakhjavani M; Ghorbanihaghjo A; Shekarchi M; Zununi Vahed S
Iran J Kidney Dis; 2019 Nov; 13(6):389-397. PubMed ID: 31880585
[TBL] [Abstract][Full Text] [Related]
6. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
[TBL] [Abstract][Full Text] [Related]
8. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
10. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
11. Serum thiols as a biomarker of disease activity in lupus nephritis.
Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
[TBL] [Abstract][Full Text] [Related]
12. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
Xue J; Yang J; Yang L; Zhou S; Ji C; Wang X; Yu N; Liu X; Chi S
J Immunol Res; 2017; 2017():6861575. PubMed ID: 28373995
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
14. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
Stanley S; Mok CC; Vanarsa K; Habazi D; Li J; Pedroza C; Saxena R; Mohan C
Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
16. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
[TBL] [Abstract][Full Text] [Related]
17. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
19. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
Choe JY; Kim SK
Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
[TBL] [Abstract][Full Text] [Related]
20. Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
Lee YH; Song GG
PLoS One; 2024; 19(5):e0303665. PubMed ID: 38753735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
